David Hadorn, MD, PhD - Medical Marijuana

Last updated on: 9/17/2014 | Author:

David Hadorn, MD, PhD Biography

Title:

Senior Research Fellow and Director at the Centre for Assessment and Prioritisation in the Department of Public Health at the University of Otago Wellington School of Medicine

Position:

Pro to the question "Should Marijuana Be a Medical Option?"

Reasoning:

“I have seen many patients with chronic pain, muscle spasms, nausea, anorexia, and other unpleasant symptoms obtain significant -- often remarkable -- relief from cannabis medicines, well beyond what had been provided by traditional (usually opiate-based) pain relievers.”

“Use of Cannabis Medicines in Clinical Practice,” , July 17, 2003

Involvement and Affiliations:

Senior Research Fellow and Director, Centre for Assessment and Prioritisation, Department of Public Health, University of Otago, Wellington School of Medicine, 2009-present
Director, Law & Economic Consulting Group (Wellington, New Zealand), 2005-2009
Medical Consultant, BC Pharmacare (Victoria, Canada), 2001-2002
Research Director, Western Canada Waiting List Project, University of Alberta (Edmonton, Canada), 1999-2001
Chief Advisor, Research and Policy Analysis, Health Funding Authority (Wellington, NZ), 1997-1999
Manager, Special Projects, National Advisory Committee on Health and Disability, Ministry of Health (Wellington, NZ), 1993-1997
Professional Consultant, RAND Corporation, 1991-1996
Post-Doctoral Fellow, Health Services Research, RAND Corporation, 1989-1991
Senior Research Associate, Center for Health Ethics and Policy, University of Colorado, 1988-1993
Emergency Physician, United Medical Staff of Boulder (Boulder, CO), 1985-1989
Director, Division of Emergency Medicine, Penn State University, 1982-1984
Assistant Professor, Medicine and Research, Penn State University, 1982-1984
Emergency physician, various California hospitals, 1979-1982
Former North American Medical Director and Medical Consultant, GW Pharmaceuticals

Education:

PhD, Philosophy, Victoria University, Wellington, 2002
MA, Philosophy, University of Colorado, 1988
MD, University of California at San Diego, 1976
BS, University of California at Irvine, 1972

Other:

Board Member, Drug Policy Forum Trust, Centre for the Study of Assessment, and New Zealand Drug Policy Forum Trust
Board of Advisors, Stop the Drug War
Member, Panel on Cost-effectiveness in Health and Medicine, US Dept. of Health and Human Services, 1993-1996
Project Director, “Developing a Clinical Practice Guideline for Congestive Heart Failure,” RAND Corporation, 1992-1996
Residency, Emergency Medicine, Louisville General Hospital, Louisville, KY, 1977-1979
Internship, Surgery University Hospital, San Diego, CA, 1976-1977

Quoted in: